Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBI-34060 Next-Day Functioning in Primary Insomnia
NCT00525941Phase 3Withdrawn
- Sponsor
- Neurocrine Biosciences
- Start
- Sep 2007
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Indiplon in Insomnia, sponsored by Neurocrine Biosciences. Planned start Sep 2007; status: withdrawn.
02
Drugs
Indiplon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00525941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525941.